TGFB1 and COVID-19: Because it has been previously shown that the chronic immune response observed with SARS-CoV-2 is mediated by TGF-β, we sought to compare the levels of TGF-β1 in plasma samples from COVID-19 (+) patients upon admission to the emergency department (ED).